Analysis of the Thrombocytopenia Effect of Chemotherapy in the Treat-ment of Solid Tumors
Objective To explore the efficacy of using Herceptin to treat thrombocytopenia in patients with solid tumor chemotherapy.Methods Fifty patients with solid tumor chemotherapy-induced thrombocytopenia admitted to the On-cology Department of Shen County People's Hospital from January 2022 to January 2023 were selected as the research subjects by target sampling method.They are divided into a reference group and a study group according to different treatment methods,with twenty-five cases in each group.The reference group received recombinant human interleu-kin 11 for injection treatment,while the study group received treatment with Herceptin.The efficacy,platelet count,and incidence of adverse reactions were compared between the two groups.Results The total effective rate of the study group was higher than that of the reference group,and the difference was statistically significant(P<0.05).After treat-ment,the platelet count in the study group was(117.82±9.63)×109/L,which was higher than(108.31±5.60)×109/L in the reference group,and the difference was statistically significant(t=4.268,P<0.05).The total incidence of adverse reactions in the study group was lower than that in the control group,and the difference was statistically significant(P<0.05).Conclusion Haiqupopa can have a positive effect on thrombocytopenia caused by solid tumor chemotherapy,im-prove platelet count levels,stabilize clinical indicators of patients,have fewer adverse reactions,and have high appli-cation value.
NETL
NSTL
万方数据
